MedPath

山西华卫药业有限公司

Ownership
-
Established
1998-12-28
Employees
-
Market Cap
-
Website
http://www.sxhwyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

NMPA:36

Drug Approvals

灯盏花素注射液

Approval Number
国药准字Z14021905
Approval Date
Mar 21, 2023
NMPA

穿心莲注射液

Approval Number
国药准字Z14021903
Approval Date
Mar 21, 2023
NMPA

柴胡注射液

Approval Number
国药准字Z14021902
Approval Date
Mar 21, 2023
NMPA

板蓝根注射液

Approval Number
国药准字Z14021901
Approval Date
Mar 21, 2023
NMPA

灯盏花素注射液

Approval Number
国药准字Z14021904
Approval Date
Mar 21, 2023
NMPA

清热解毒注射液

Approval Number
国药准字Z14021907
Approval Date
Mar 21, 2023
NMPA

Solvent of Ailepgen

Product Name
变应原(抗原)溶媒
Approval Number
国药准字H20057466
Approval Date
Mar 21, 2023
NMPA

冠心宁注射液

Approval Number
国药准字Z14021813
Approval Date
Mar 21, 2023
NMPA

Ozagrel Sodium Injection

Product Name
奥扎格雷钠注射液
Approval Number
国药准字H20067343
Approval Date
Feb 24, 2022
NMPA

Ozagrel Sodium Injection

Product Name
奥扎格雷钠注射液
Approval Number
国药准字H20067342
Approval Date
Feb 24, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.